Alvogen To Merge Korean Units, Plans Asian Expansion
This article was originally published in PharmAsia News
Executive Summary
U.S.-based pharmaceutical company Alvogen will merge its two South Korean subsidiaries - Kunwha Pharm and Dream Pharma - to create a new unit, Alvogen Korea, in June as part of its goal to become one of the top five regional players in the Asia-Pacific market. The consolidated entity will become one of the largest generic pharma businesses in the country.